Eliem Therapeutics所有資訊

Eliem Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等

04/12 18:53 (美東)

Eliem Therapeutics | 4：持股變動聲明-高管 Morisset Valerie

04/08 17:38 (美東)

Eliem Therapeutics | 4：持股變動聲明-高管 Pimblett Emily

03/20 16:38 (美東)

Eliem Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等

03/18 16:51 (美東)

Eliem Therapeutics | 4：持股變動聲明-高管 Morisset Valerie

03/04 11:10 (美東)

Eliem Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)

02/07 11:56 (美東)

Eliem Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%)等

2023/11/17 16:30 (美東)

Eliem Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)

2023/11/13 17:13 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.

2023/05/22 17:22 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事 Tate Simon

2023/05/22 17:13 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事 Ratcliffe Liam

2023/05/22 17:11 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事 Dunn Judith

2023/05/22 17:08 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事 Rosenberg Adam Joseph

2023/05/22 17:05 (美東)

Eliem Therapeutics | 4：持股變動聲明-董事會執行主席 Levin Andrew David

2023/05/22 17:02 (美東)

Eliem Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(48.8%),Peter Kolchinsky(48.8%)等

2023/04/10 17:01 (美東)

Eliem Therapeutics | 3：首次持股聲明-首席會計師 Pimblett Emily

2023/03/21 10:21 (美東)

Eliem Therapeutics | 4：持股變動聲明-高管 Morisset Valerie

2023/03/14 17:04 (美東)

Eliem Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Intermediate Capital Investments Limited(7.5%),Intermediate Capital Group plc(7.5%)

2023/03/08 16:00 (美東)

Eliem Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Samlyn Capital, LLC(0%),Samlyn, LP(0%)等

2023/02/14 14:22 (美東)

Eliem Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Braden M Leonard(7.1%),BML Investment Partners, L.P.(6.9%)

2023/02/08 16:35 (美東)